The trial design doesn't include measurement of the MMSE score at 5 weeks, but, that doesn't mean that it wasn't taken.
This is an adaptive trial and AVXL, and those conducting the trial, may have wanted the 5 week interim info in order to determine dosage changes for the next patients.